+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transjugular Intrahepatic Portosystemic Shunt Market by Product Type (Accessory Devices, Stents), Procedure Type (Elective Shunts, Emergency Shunts), Material Type, Application, End-User - Global Forecast 2025-2030- Product Image
Transjugular Intrahepatic Portosystemic Shunt Market by Product Type (Accessory Devices, Stents), Procedure Type (Elective Shunts, Emergency Shunts), Material Type, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Transjugular Intrahepatic Portosystemic Shunt Market by Product Type (Accessory Devices, Stents), Procedure Type (Elective Shunts, Emergency Shunts), Material Type, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055318
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transjugular Intrahepatic Portosystemic Shunt Market grew from USD 102.55 million in 2024 to USD 106.78 million in 2025. It is expected to continue growing at a CAGR of 4.27%, reaching USD 131.81 million by 2030.

The transjugular intrahepatic portosystemic shunt (TIPS) procedure represents a pivotal development in the realm of interventional radiology, offering critical relief to patients suffering from complex liver conditions. By creating a channel within the liver to connect the portal and systemic venous systems, TIPS essentially alleviates the complications associated with portal hypertension and its related disorders. Over the years, this innovative treatment has evolved markedly, driven by advances in device technology, enhanced procedural techniques, and growing clinical expertise. The market has witnessed a steady expansion as healthcare systems continue to recognize the benefits of minimally invasive procedures, leading to improved patient outcomes and reduced recovery times. At its core, the evolution of TIPS reflects a broader commitment to medical innovation and patient-centered care. Alongside technological progress, there is an increasing emphasis on data-supported decision-making and cost-effective therapies. This introductory overview sets the stage for an in-depth exploration of the market dynamics, transformational shifts, detailed segmentation insights, and emerging trends that define the current TIPS landscape.

As stakeholders continue to assess both the clinical advantages and economic implications of TIPS, it becomes paramount to examine the interplay between the technological advancements and the evolving regulatory environment. This executive summary aims to provide a comprehensive perspective that extends beyond basic procedural information to include market determinants, competitive positioning, and future growth strategies. The subsequent sections will unfold a detailed narrative, guiding the reader through each critical aspect of this dynamic market landscape.

Transformative Shifts in the TIPS Market Landscape

The TIPS market has recently experienced transformative shifts that are reshaping the entire landscape of interventional radiology. Technological advancements have triggered a paradigm shift in the design and functionality of associated devices, enabling higher precision, safety and improved patient recovery outcomes. Clinicians now have access to state-of-the-art devices that offer enhanced imaging capabilities, innovative materials that support better biocompatibility, and cutting-edge delivery systems that have redefined procedural success. These innovations are complemented by augmented reality and robotics, which further refine the accuracy of the procedure and reduce post-surgical complications.

Regulatory changes have also played a significant role in this market transformation. Increased emphasis on patient safety protocols and the implementation of strict quality control measures have fueled a robust environment for research and development. Stakeholders are increasingly investing in clinical studies to validate new device efficacy, thereby streamlining the path to regulatory approvals. The growing acknowledgment of TIPS as a life-enhancing technique has encouraged a multitude of collaborations between healthcare providers, research institutions, and manufacturing firms, each playing an essential role in advancing procedural standards.

Furthermore, the market is undergoing a notable shift towards personalized treatment approaches and improved patient management solutions. Enhanced data analytics and digital integration are supporting clinical decision-making processes. As the industry moves forward, strategic partnerships and continuous innovations are set to drive market growth, ensuring that the TIPS landscape remains both adaptable and responsive to emerging healthcare challenges.

Key Segmentation Insights in the TIPS Market

A thorough understanding of market segmentation provides valuable insights into the expanding TIPS landscape. The segmentation strategy begins with product types where the focus is divided between accessory devices and stents. In the accessory devices segment, elements such as balloon expanders, catheters, and guiding wires have been integral to procedural success, offering nuanced solutions tailored to specific clinical requirements. Simultaneously, the stents segment includes bare metal stents, drug-eluting stents, and sectional stents, each addressing varied clinical scenarios and patient profiles by focusing on different therapeutic benefits and safety profiles.

Additionally, segmentation by procedure type distinguishes elective shunts from emergency shunt procedures, highlighting the importance of timely intervention while demonstrating the flexibility of the treatment approach based on patient urgency. With this approach, clinicians can optimize therapy based both on clinical presentation and logistical considerations. The material type segmentation divides the market into devices made from metallic stents compared to those using polymers, ensuring that each material’s properties - such as durability, compatibility, and response to physiological conditions - offer a distinct advantage in meeting a range of clinical demands.

Moreover, when viewing the TIPS market through the lens of application, conditions such as Budd-Chiari Syndrome, Hepatitis C, liver cirrhosis, and portal hypertension are carefully analyzed to understand distinct treatment protocols and their corresponding market dynamics. Lastly, segmentation based on the end-user includes ambulatory surgical centers, hospitals, research institutes, and specialty clinics. This segmentation provides a deep dive into how each end-user adapts the technology to address varied patient demographics and procedural complexities. Collectively, these segmentation insights unravel the multi-faceted dimensions of the TIPS market and underline the importance of tailored solutions in a rapidly evolving healthcare environment.

Based on Product Type, market is studied across Accessory Devices and Stents. The Accessory Devices is further studied across Balloon Expanders, Catheters, and Guiding Wires. The Stents is further studied across Bare Metal Stents, Drug-Eluting Stents, and Sectional Stents.

Based on Procedure Type, market is studied across Elective Shunts and Emergency Shunts.

Based on Material Type, market is studied across Metallic Stents and Polymers.

Based on Application, market is studied across Budd-Chiari Syndrome, Hepatitis C, Liver Cirrhosis, and Portal Hypertension.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Research Institutes, and Specialty Clinics.

Key Regional Insights: Market Dynamics by Geography

The TIPS market exhibits distinct regional characteristics that underline the importance of geographical dynamics in influencing market growth and technological adoption. In the Americas, a blend of advanced healthcare infrastructure, strong regulatory oversight, and a high degree of clinical specialization continues to drive innovation. Here, the emphasis on integrating new technologies with established treatment practices has created robust demand for advanced interventional devices and improved procedural methodologies.

In the Europe, Middle East & Africa region, market growth is propelled by a solid legacy of clinical excellence combined with increasing investment in research and development. This diverse region benefits from well-established networks of specialized clinics and hospitals, which foster rapid adoption of novel techniques and devices. The synergistic relationship between regulatory bodies and clinical experts also bolsters the region’s ability to implement high standards of patient care while pursuing technological advances.

Asia-Pacific demonstrates the potential for rapid market expansion driven by rising healthcare expenditures, improved access to advanced medical technologies, and a growing number of tertiary care centers. With an increasingly large patient pool and progressive government initiatives aimed at enhancing healthcare accessibility, countries in this region are poised to achieve significant advancements in interventional radiology. The regional insights thus paint a picture of a globally integrated market, where local nuances and regional policies interact to define the pace and pattern of market evolution. These insights illuminate the strategic importance of tailoring market approaches to specific regional demands and infrastructure capabilities.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights in the TIPS Market

An analysis of the competitive landscape identifies several key companies as central players in the TIPS market. AngioDynamics Inc. and Argon Medical Devices, Inc. lead the charge with potent innovation pipelines and comprehensive service portfolios. Meanwhile, Becton, Dickinson and Company, along with Boston Scientific Corporation, have demonstrated robust leadership through extensive product lines and integrated solutions that cater to evolving clinical needs. Cook Group Incorporated and Medtronic have strategically positioned themselves in the market by cultivating strong research networks and leveraging technological expertise.

In addition to these market leaders, Merit Medical Systems, Inc. and Siemens Healthcare Limited have emerged as significant contenders by focusing on both device excellence and sustainable growth practices. Sirtex Medical Inc. and Terumo Medical Corporation have reinforced competitive differentiation through advanced technological components and comprehensive post-market support for practitioners. The contributions of W. L. Gore & Associates, Inc. further encapsulate the market’s drive toward innovative materials and procedural efficiency. Overall, the interplay between these industry leaders fosters an environment rich with technological advancements, clinical trials, and product improvements that are set to further elevate the standards of interventional radiology on a global scale.

The report delves into recent significant developments in the Transjugular Intrahepatic Portosystemic Shunt Market, highlighting leading vendors and their innovative profiles. These include AngioDynamics Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Medtronic, Merit Medical Systems, Inc., Siemens Healthcare Limited, Sirtex Medical Inc., Terumo Medical Corporation, and W. L. Gore & Associates, Inc..

Actionable Recommendations for Industry Leaders in the Evolving Market

Given the dynamic evolution of the TIPS market, it is vital for industry leaders to adopt a forward-thinking, multipronged strategy. A deep investment in research and development should be a priority, ensuring that new product innovations not only meet current clinical challenges but are also adaptable to future therapeutic demands. Enhancing collaboration between clinical practitioners, biomedical engineers, and regulatory authorities can lead to accelerated validation processes and more robust product pipelines.

Leaders should also focus on developing technology platforms that seamlessly integrate with digital health innovations and real-time data analytics. This digital integration will enhance patient monitoring, streamline post-procedure care, and ultimately improve treatment outcomes. Emphasizing continuous professional development and targeted training sessions will empower healthcare professionals to adapt rapidly to advanced procedural techniques. Additionally, it is essential to invest in market intelligence tools that offer granular insights into regional trends and emerging market demands, providing the groundwork for data-driven decision-making.

Finally, forming strategic alliances with academic and research institutions can open new avenues for joint studies and clinical trials, which are critical for establishing the safety and efficacy of emerging technologies. This holistic approach not only fortifies competitive positioning but also ensures industry resilience in the face of evolving market challenges.

Synthesizing the Future of TIPS

The TIPS market stands on the cusp of transformative growth, shaped by technological breakthroughs, regulatory evolutions, and changing clinical paradigms. Close examination of key market segments, regional dynamics, and competitive landscapes reveals an industry poised for rapid innovation and significant expansion. As the market continues to evolve, the integration of advanced technologies and personalized treatment approaches will play a decisive role in defining future care standards.

In summary, a balanced focus on product innovation, strategic collaborations, and regional customization of market strategies will be essential for navigating this dynamic landscape. Industry stakeholders equipped with actionable insights and a proactive vision are set to define the next chapter in interventional radiology, ensuring robust patient outcomes and sustained market leadership.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of liver diseases such as cirrhosis and portal hypertension
5.1.1.2. Increasing adoption of minimally invasive surgical procedures due to faster recovery times
5.1.2. Restraints
5.1.2.1. Safety concerns and potential complications associated with intrahepatic portosystemic shunt procedures
5.1.3. Opportunities
5.1.3.1. Developing personalized TIPS treatment plans leveraging artificial intelligence for better patient outcomes
5.1.3.2. Capitalizing on technological advancements in materials to enhance TIPS device efficacy and safety
5.1.4. Challenges
5.1.4.1. Insufficient insurance coverage and reimbursement issues related to TIPS procedures
5.2. Market Segmentation Analysis
5.2.1. Product Type: Rising need for accessory devices for minimally invasive surgical procedures
5.2.2. Application: Increasing necessity for TIPS procedure for curing portal hypertension
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Transjugular Intrahepatic Portosystemic Shunt Market, by Product Type
6.1. Introduction
6.2. Accessory Devices
6.2.1. Balloon Expanders
6.2.2. Catheters
6.2.3. Guiding Wires
6.3. Stents
6.3.1. Bare Metal Stents
6.3.2. Drug-Eluting Stents
6.3.3. Sectional Stents
7. Transjugular Intrahepatic Portosystemic Shunt Market, by Procedure Type
7.1. Introduction
7.2. Elective Shunts
7.3. Emergency Shunts
8. Transjugular Intrahepatic Portosystemic Shunt Market, by Material Type
8.1. Introduction
8.2. Metallic Stents
8.3. Polymers
9. Transjugular Intrahepatic Portosystemic Shunt Market, by Application
9.1. Introduction
9.2. Budd-Chiari Syndrome
9.3. Hepatitis C
9.4. Liver Cirrhosis
9.5. Portal Hypertension
10. Transjugular Intrahepatic Portosystemic Shunt Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Research Institutes
10.5. Specialty Clinics
11. Americas Transjugular Intrahepatic Portosystemic Shunt Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Transjugular Intrahepatic Portosystemic Shunt Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Transjugular Intrahepatic Portosystemic Shunt Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Scenario Analysis
14.3.1. Argon Medical enhances TIPS procedure with innovative liver management devices
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET MULTI-CURRENCY
FIGURE 2. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET MULTI-LANGUAGE
FIGURE 3. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET RESEARCH PROCESS
FIGURE 4. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 15. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 17. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 19. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 21. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 27. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET DYNAMICS
TABLE 7. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BALLOON EXPANDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY GUIDING WIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY SECTIONAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ELECTIVE SHUNTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY EMERGENCY SHUNTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BUDD-CHIARI SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY LIVER CIRRHOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PORTAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 58. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 59. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 65. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 95. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 96. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 97. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 98. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 102. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 103. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 104. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 105. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 116. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 117. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 118. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 119. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 158. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 159. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 160. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 161. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 178. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 180. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 181. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 182. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 183. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 187. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 188. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 189. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 194. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 201. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 202. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 203. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 204. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 208. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 209. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 210. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 211. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 222. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 223. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 224. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 243. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 250. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 251. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 253. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 257. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 258. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 259. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 260. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
T

Companies Mentioned

  • AngioDynamics Inc.
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Medtronic
  • Merit Medical Systems, Inc.
  • Siemens Healthcare Limited
  • Sirtex Medical Inc.
  • Terumo Medical Corporation
  • W. L. Gore & Associates, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 106.78 Million
Forecasted Market Value ( USD ) by 2030 $ 131.81 Million
Compound Annual Growth Rate4.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Glaucoma Aqueous Shunt Device Market by Material, End User, Surgery Type - Global Forecast 2025-2030 - Product Image

Glaucoma Aqueous Shunt Device Market by Material, End User, Surgery Type - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Cerebrospinal Fluid Management Devices Market by Product, Age Group, End User - Global Forecast 2025-2030 - Product Image

Cerebrospinal Fluid Management Devices Market by Product, Age Group, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Hydrocephalus Shunts - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Hydrocephalus Shunts - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Hydrocephalus Shunts - Global Strategic Business Report - Product Image

Hydrocephalus Shunts - Global Strategic Business Report

  • Report
  • 365 Pages
  • Global
From
Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 62 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.